Washington, Aug 17 : Non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision, found one of only two studies of its kind.

««  Read More      Comments Off

( Tufts University, Health Sciences ) In one of only two studies of its kind, a study from researchers at Tufts University demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision. The team developed nanoparticles to deliver therapeutic genes to the retina and found that treated [...]

««  Read More      Comments Off

The easy accessibility of the eye and the established link between specific genetic defects and ocular disorders offer hope for using gene therapy to provide long-term therapeutic benefit. Two reports in the current issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com), describe the effective replacement of a …

««  Read More      Comments Off

In one of only two studies of its kind, scientists demonstrate that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision. The team developed nanoparticles to deliver therapeutic genes to the retina and found that treated mice temporarily retained more eyesight than controls. The study brings researchers closer [...]

««  Read More      Comments Off

The easy accessibility of the eye and the established link between specific genetic defects and ocular disorders offer hope for using gene therapy to provide long-term therapeutic benefit. Two reports in the current issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc., describe the effective replacement of a human gene [...]

««  Read More      Comments Off

The easy accessibility of the eye and the established link between specific genetic defects and ocular disorders offer hope for using gene therapy to provide long-term therapeutic benefit. Two new reports describe the effective replacement of a human gene to preserve photoreceptor function in a mouse model of severe retinal degeneration.

««  Read More      Comments Off

The easy accessibility of the eye and the established link between specific genetic defects and ocular disorders offer hope for using gene therapy to provide long-term therapeutic benefit. Two reports in the current issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc., describe the effective replacement of a human gene [...]

««  Read More      Comments Off

An ingredient in the venom of the “deathstalker” scorpion could help gene therapy become an effective treatment for brain cancer, scientists are reporting. The substance allows therapeutic genes – genes that treat disease – to reach more brain cancer cells than current approaches, according to the study in ACS Nano, a monthly journal. Miqin Zhang [...]

««  Read More      Comments Off

( Nationwide Children’s Hospital ) Parent Project Muscular Dystrophy, the largest nonprofit organization in the United States focused on finding a cure for Duchenne muscular dystrophy, announced that PPMD will award a $600,000 grant to Nationwide Children’s Hospital in Columbus, Ohio, to conduct clinical testing of a promising gene therapy technique for muscle disease.

««  Read More      Comments Off

Dr. Jerry Mendell Leading Follistatin Gene Therapy MIDDLETOWN, Ohio, Aug. 9 /PRNewswire-USNewswire/ — Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), will award a $600,000 grant to Nationwide Children’s Hospital in Columbus, Ohio to conduct clinical testing of a promising [...]

««  Read More      Comments Off

An emerging therapy that attacks cancer cells continues to show promise, most recently in two international studies on women who have breast and ovarian cancer and are carriers of cancer-causing mutations particularly prevalent among Ashkenazi Jews.

««  Read More      Comments Off

Washington, Aug 12 : Scientists have found that an ingredient in the venom of the ‘deathstalker’ scorpion could help gene therapy become an effective treatment for brain cancer.

««  Read More      Comments Off

An ingredient in the venom of the “deathstalker” scorpion could help gene therapy become an effective treatment for brain cancer, scientists are reporting. The substance allows therapeutic genes — genes that treat disease — to reach more brain cancer cells than current approaches, according to a new study.

««  Read More      Comments Off

An ingredient in the venom of the “deathstalker” scorpion could help gene therapy become an effective treatment for brain cancer, scientists are reporting. The substance allows therapeutic genes – genes that treat disease – to reach more brain cancer cells than current approaches, according to the study in ACS Nano, a monthly journal.

««  Read More      Comments Off

Therapy’s potential could extend beyond care of epidermolysis bullosa, researchers say.

««  Read More      Comments Off

A new analysis of the California Teachers Study, which analyzed hormone replacement therapy use among 2,857 women for almost 10 years, underscores the need for personalized risk-benefit discussions before women begin hormone therapy.”This is evidence that the story is complicated,” said Tanmai Saxena, an M.D./Ph.D. student at the Keck School of Medicine at the University [...]

««  Read More      Comments Off

Understanding the underlying genetic weakness of certain types of cancer may lead to targeted therapy and provide the key to effective treatment, a new study suggests. An international consortium of researchers has shown that an investigational drug, Olaparib, can reduce the size of tumors in women with advanced hereditary ovarian cancer with BRCA gene mutations.

««  Read More      Comments Off

FORT LEE, N.J., Aug. 12 /PRNewswire-FirstCall/ — Neurologix, Inc. (OTCBB: NRGX) (the “Company”), a biotechnology company developing innovative gene therapies for the brain and central nervous system (”CNS”), today reported its financial results for the three and six months ended June 30, 2010. “We are extremely pleased with the continued success of NLX-P101, our Parkinson’s [...]

««  Read More      Comments Off

I have read with interest Ben Bovas two columns describing his personal predictions that genetics and gene therapy will play an important future role in health care.

««  Read More      Comments Off

DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/9e090a/cell_therapy_tec) has announced the addition of Jain PharmaBiotech’s new report “Cell Therapy – Technologies, Markets and Companies” to their offering. This report describes and evaluates cell therapy technologies and methods, which have already started to play an important …

««  Read More      Comments Off